Fresenius Kabi, a pharmaceutical company, has filed a lawsuit to prevent the state Dept. of Corrections from using lethal injection drugs in the scheduled execution of Carey Dean Moore Aug. 14.
Danielle Conrad, executive director of ACLU of Nebraska, has the following statement:
“The ACLU commends Fresenius Kabi for intervening to ensure their products were not obtained illegally or are being used for illicit purposes. Such last-minute efforts would be unnecessary if the Nebraska Department of Corrections had simply complied with our state’s open records law. The ACLU’s relentless legal work provided key details that helped make this case possible. While more states are turning away from the death penalty, Nebraska officials are rushing to carry out an execution cloaked in secrecy with an untested four-drug scheme that carries immeasurable risks for unnecessary pain and a botched execution. Transparency and key facts like the source of execution drugs matter most when government seeks to carry out its most grave and irrevocable function.”
